プロテイナーゼKの世界市場レポート 2025年

プロテイナーゼKの市場規模は今後数年で急成長が見込まれます。2029年には81億9,000万米ドルに成長し、CAGRは11.2％となります。予測期間の成長は、分子診断の継続的成長、精密医療の進歩、バイオ医薬品製造の拡大、プロテオミクスとゲノミクスの研究、法医学における応用の増加などに起因しています。予測期間における世界の主な動向には、製薬業界の成長、技術の進歩、市場競争と価格設定、持続可能なアニマルフリーバリエーション、世界のパンデミックの影響などが含まれます。

予想されるプロテイナーゼK市場の成長は、慢性疾患の有病率の増加によって牽引されると予想されます。1年以上続き、継続的な治療を必要とする慢性疾患は、プロテイナーゼKの重要な使用対象です。酵素は予防と治療の両面で重要な役割を果たしており、様々な慢性疾患に関連するウイルスからDNAやRNAの抽出・分離を容易にします。例えば、2023年1月に国立医学図書館が発表したデータによると、米国では50歳以上で少なくとも1つの慢性疾患を持つ人の数が増加し、2050年には1億4,266万人に達すると予測されています。このことは、慢性疾患と闘う人々のニーズに対応する上で、プロテイナーゼKの重要性が増していることを強調しています。

感染症、特に結核の罹患率の上昇が、プロテイナーゼK市場の今後の成長を牽引すると予測されています。結核は結核菌による細菌感染症で、主に肺を侵すが、他の部位にも影響を及ぼすことがあります。プロテイナーゼKは、結核菌からDNAやRNAを抽出・分離する結核研究に使用されています。例えば、2024年2月、英国政府機関GOV.UKは、2023年のイングランドにおける結核患者数が10.7％増加し、2022年の4,380人から4,850人に増加すると報告しています。このように、結核のような感染症の罹患率の増加は、プロテイナーゼK市場を押し上げると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界プロテイナーゼK PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のプロテイナーゼK市場：成長率分析
• 世界のプロテイナーゼK市場の実績：規模と成長, 2019-2024
• 世界のプロテイナーゼK市場の予測：規模と成長, 2024-2029, 2034F
• 世界プロテイナーゼK総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のプロテイナーゼK市場：形態別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 凍結乾燥粉末
• 液体
• 世界のプロテイナーゼK市場治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 糖尿病
• 腫瘍学
• 心臓病学
• 腎臓学
• 自己免疫疾患
• 神経学
• その他の治療領域
• 世界のプロテイナーゼK市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゲノムDNAとRNAの分離と精製
• インサイチューハイブリダイゼーション
• ミトコンドリアの分離
• 酵素除去
• 世界のプロテイナーゼK市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 契約調査機関
• 学術機関
• バイオテクノロジー企業
• 診断検査室
• 世界のプロテイナーゼK市場、凍結乾燥粉末形態のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高純度凍結乾燥粉末
• 標準グレードの凍結乾燥粉末
• 世界のプロテイナーゼK市場、液体形態のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• すぐに使える液体
• 濃縮液体溶液

第7章 地域別・国別分析

• 世界のプロテイナーゼK市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のプロテイナーゼK市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• プロテイナーゼK市場：競合情勢
• プロテイナーゼK市場：企業プロファイル
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Worthington Biochemical Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sigma-Aldrich Co. LLC
• Behemoth Inteligencia para os Negocios LTDA
• Codexis Inc.
• Beijing SBS Genetech Co. Ltd
• Hoffmann-La Roche Ltd
• Amicogen Inc
• Amano Enzyme Inc.
• Sisco Research Laboratories Pvt. Ltd.
• Promega Corporation
• Bioline Diagnostics LLP
• Biocompare
• BioVision Inc.
• Creative Enzymes
• G-Biosciences
• Advanced Enzymes Technologies

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• プロテイナーゼK市場2029：新たな機会を提供する国
• プロテイナーゼK市場2029：新たな機会を提供するセグメント
• プロテイナーゼK市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Proteinase K, a serine protease derived from the mold Tritirachium album, serves as a valuable enzyme for the deactivation of protein contaminants in sample preparations. Widely utilized in DNA extraction processes, this enzyme comes in two primary forms lyophilized powder and liquid.

The lyophilized powder form is obtained through a dehydration process involving freezing and vacuum removal of water. Proteinase K finds applications across various therapeutic areas such as infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, and neurology. Its uses extend to isolation and purification of genomic DNA and RNA, in situ hybridization, mitochondria isolation, and enzyme removal.Target customers for Proteinase K include contract research organizations, academic institutes, biotechnology companies, and diagnostics laboratories. Its role in facilitating the efficient processing of samples makes it a key component in research and diagnostic workflows within the specified industries and applications.

The proteinase k market research report is one of a series of new reports from The Business Research Company that provides proteinase k market statistics, including proteinase k industry global market size, regional shares, competitors with a proteinase k market share, detailed proteinase k market segments, market trends and opportunities, and any further data you may need to thrive in the proteinase k industry. This proteinase k market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The proteinase K market size has grown strongly in recent years. It will grow from$4.89 billion in 2024 to $5.36 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to expanding biotechnology and life sciences research, diagnostic testing advancements, pharmaceutical development needs, bioprocessing and protein purification, quality control in food and beverages

The proteinase K market size is expected to see rapid growth in the next few years. It will grow to $8.19 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to continued growth in molecular diagnostics, advancements in precision medicine, biopharmaceutical manufacturing expansion, research in proteomics and genomics, and increased application in forensic sciences. Major trends in the forecast period include pharmaceutical industry growth, technological advancements, market competition and pricing, sustainable and animal-free variants, and global pandemic impact.

The anticipated growth of the proteinase K market is expected to be driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting more than a year and requiring continuous medical treatment, are a significant target for proteinase K usage. The enzyme plays a crucial role in both preventative and therapeutic applications, facilitating the extraction and isolation of DNA and RNA from viruses associated with various chronic diseases. For instance, data from the National Library of Medicine in January 2023 projected a rise in the number of individuals aged 50 and older with at least one chronic condition in the US, reaching 142.66 million by 2050. This underscores the growing significance of proteinase K in addressing the needs of a population grappling with chronic diseases.

The rising incidence of infectious diseases, particularly tuberculosis, is projected to drive growth in the proteinase K market in the future. Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis, which primarily affects the lungs but can also impact other areas of the body. Proteinase K is used in TB research for the extraction and isolation of DNA and RNA from the Mycobacterium tuberculosis bacterium. For example, in February 2024, the UK government department GOV.UK reported a 10.7% increase in tuberculosis cases in England in 2023, rising from 4,380 in 2022 to 4,850. Thus, the growing incidence of infectious diseases like tuberculosis is expected to boost the proteinase K market.

The proteinase K market is witnessing a notable trend towards product innovation, with major companies actively launching novel products to strengthen their positions. One such example is Biocatalysts Ltd., a UK-based biotechnology company, which introduced Proteocut K. This high-quality and cost-effective alternative to liquid proteinase K is a subtilisin-type serine protease with broad substrate specificity, suitable for a variety of life science applications. Its efficient hydrolysis of various proteins is attributed to its broad pH profile (6.0 - 10.0) and temperature range (40 -70°C). This innovative offering enhances the choices available in the proteinase K market, providing users with a versatile enzyme solution.

Companies are focused on continuous product development to stay competitive. ArcticZymes Technologies ASA, a Norway-based biotechnology company, exemplifies this by upscaling production and launching a glycerol-free version of ArcticZymes Proteinase. Known for its high activity and stability, this enzyme is valuable in molecular biology protocols, diagnostics, and bioprocessing. The glycerol-free variant offers enhanced stability at -20°C for up to one year, making it suitable for lyophilization and automated processes.

In January 2023, Lighthouse Pharma, a US-based biopharmaceutical company, acquired the small molecule proteinase inhibitor portfolio from Quince Therapeutics Inc. This acquisition positions Lighthouse Pharma to advance the development of gingipain inhibitors for dementia and other disorders, offering innovative treatment options. Quince Therapeutics Inc., a US-based biotechnology company specializing in proteinase inhibitors, contributes valuable assets to Lighthouse Pharma's research and development efforts.

Major companies operating in the proteinase K market include Merck KGaA, QIAGEN NV, Thermo Fisher Scientific Inc., F Hoffmann-La Roche Ltd., Worthington Biochemical Corporation, Sigma-Aldrich Co. LLC, Behemoth Inteligencia para os Negocios LTDA, Codexis Inc., Beijing SBS Genetech Co. Ltd, Hoffmann-La Roche Ltd, Amicogen Inc, Amano Enzyme Inc., Sisco Research Laboratories Pvt. Ltd., Promega Corporation, Bioline Diagnostics LLP, Biocompare, BioVision Inc., Creative Enzymes, G-Biosciences, Advanced Enzymes Technologies, Cell Signaling Technology Inc., Dyadic International, Amresco LLC, Abcam plc, Bio Basic Inc., BioChain Institute Inc., BioLegend Inc., Bio-Rad Laboratories Inc., Enzo Life Sciences Inc., GenScript Biotech Corporation

North America was the largest region in the global proteinase k market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global proteinase k market during the forecast period. The regions covered in the proteinase k market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the proteinase k market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The proteinase K market consists of sales of acid proteinase, neutral proteinase, and alkaline proteinase. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Proteinase K Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on proteinase k market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for proteinase k ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The proteinase k market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Form: Lyophilized Powder Form; Liquid Form
• 2) By Therapeutic Area: Infectious Diseases; Diabetes; Oncology; Cardiology; Nephrology; Autoimmune Diseases; Neurology; Other Therapeutic Areas
• 3) By Application: Isolation And Purification Of Genomic DNA And RNA; In Situ Hybridization; Mitochondria Isolation; Enzyme Removal
• 4) By End-Use: Contract Research Organization; Academic Institutes; Biotechnology Companies; Diagnostic Laboratories
• Subsegments:
• 1) By Lyophilized Powder Form: High Purity Lyophilized Powder; Standard Grade Lyophilized Powder
• 2) By Liquid Form: Ready-To-Use Liquid; Concentrated Liquid Solutions
• Companies Mentioned: Merck KGaA; QIAGEN NV; Thermo Fisher Scientific Inc.; F Hoffmann-La Roche Ltd.; Worthington Biochemical Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Proteinase K Market Characteristics

3. Proteinase K Market Trends And Strategies

4. Proteinase K Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Proteinase K Growth Analysis And Strategic Analysis Framework

• 5.1. Global Proteinase K PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Proteinase K Market Growth Rate Analysis
• 5.4. Global Proteinase K Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Proteinase K Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Proteinase K Total Addressable Market (TAM)

6. Proteinase K Market Segmentation

• 6.1. Global Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lyophilized Powder Form
• Liquid Form
• 6.2. Global Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune Diseases
• Neurology
• Other Therapeutic Areas
• 6.3. Global Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Isolation And Purification Of Genomic DNA And RNA
• In Situ Hybridization
• Mitochondria Isolation
• Enzyme Removal
• 6.4. Global Proteinase K Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Research Organization
• Academic Institutes
• Biotechnology Companies
• Diagnostic Laboratories
• 6.5. Global Proteinase K Market, Sub-Segmentation Of Lyophilized Powder Form, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High Purity Lyophilized Powder
• Standard Grade Lyophilized Powder
• 6.6. Global Proteinase K Market, Sub-Segmentation Of Liquid Form, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ready-To-Use Liquid
• Concentrated Liquid Solutions

7. Proteinase K Market Regional And Country Analysis

• 7.1. Global Proteinase K Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Proteinase K Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Proteinase K Market

• 8.1. Asia-Pacific Proteinase K Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Proteinase K Market

• 9.1. China Proteinase K Market Overview
• 9.2. China Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Proteinase K Market

• 10.1. India Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Proteinase K Market

• 11.1. Japan Proteinase K Market Overview
• 11.2. Japan Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Proteinase K Market

• 12.1. Australia Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Proteinase K Market

• 13.1. Indonesia Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Proteinase K Market

• 14.1. South Korea Proteinase K Market Overview
• 14.2. South Korea Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Proteinase K Market

• 15.1. Western Europe Proteinase K Market Overview
• 15.2. Western Europe Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Proteinase K Market

• 16.1. UK Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Proteinase K Market

• 17.1. Germany Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Proteinase K Market

• 18.1. France Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Proteinase K Market

• 19.1. Italy Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Proteinase K Market

• 20.1. Spain Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Proteinase K Market

• 21.1. Eastern Europe Proteinase K Market Overview
• 21.2. Eastern Europe Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Proteinase K Market

• 22.1. Russia Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Proteinase K Market

• 23.1. North America Proteinase K Market Overview
• 23.2. North America Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Proteinase K Market

• 24.1. USA Proteinase K Market Overview
• 24.2. USA Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Proteinase K Market

• 25.1. Canada Proteinase K Market Overview
• 25.2. Canada Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Proteinase K Market

• 26.1. South America Proteinase K Market Overview
• 26.2. South America Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Proteinase K Market

• 27.1. Brazil Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Proteinase K Market

• 28.1. Middle East Proteinase K Market Overview
• 28.2. Middle East Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Proteinase K Market

• 29.1. Africa Proteinase K Market Overview
• 29.2. Africa Proteinase K Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Proteinase K Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Proteinase K Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Proteinase K Market Competitive Landscape And Company Profiles

• 30.1. Proteinase K Market Competitive Landscape
• 30.2. Proteinase K Market Company Profiles
  • 30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Worthington Biochemical Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Proteinase K Market Other Major And Innovative Companies

• 31.1. Sigma-Aldrich Co. LLC
• 31.2. Behemoth Inteligencia para os Negocios LTDA
• 31.3. Codexis Inc.
• 31.4. Beijing SBS Genetech Co. Ltd
• 31.5. Hoffmann-La Roche Ltd
• 31.6. Amicogen Inc
• 31.7. Amano Enzyme Inc.
• 31.8. Sisco Research Laboratories Pvt. Ltd.
• 31.9. Promega Corporation
• 31.10. Bioline Diagnostics LLP
• 31.11. Biocompare
• 31.12. BioVision Inc.
• 31.13. Creative Enzymes
• 31.14. G-Biosciences
• 31.15. Advanced Enzymes Technologies

32. Global Proteinase K Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Proteinase K Market

34. Recent Developments In The Proteinase K Market

35. Proteinase K Market High Potential Countries, Segments and Strategies

• 35.1 Proteinase K Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Proteinase K Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Proteinase K Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer